Trial Details
NOT_YET_RECRUITINGBasic Information
| Clinical ID | c398 |
|---|---|
| Identifier | NCT06788340 |
| Trial Title | MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis |
| Interventions | DRUG: PK-model to decide when to dose Vedolizumab and Ustekinumab |
Participant Information
| Sponsor | Odense University Hospital |
|---|---|
| City | Aalborg |
| Country/Region | Denmark |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-05-01 |
|---|---|
| Primary Completion Date | 2027-03-01 |
| Completion Date | 2027-03-14 |